Human fibroblasts in culture take up exogenous [choline-Me-3H,32P]sphingomyelin (SM) from the medium and incorporate it into cellular SM and phosphatidylcholine [Spence, Clarke & Cook (1983) (1) the P-Cho pool in control and NP cells incubated with exogenous labelled SM has a specific radioactivity intermediate between that of SM and PtdCho; (2) expansion of the intracellular P-Cho pool by incubation with exogenous choline reduces the incorporation of [3H]choline from SM into PtdCho; and (3) incorporation of P-Cho from SM into PtdCho is decreased at the non-permissive temperature in Chinese hamster ovary cells with a temperature-sensitive mutation in the cytidylyltransferase reaction. These results suggest that incorporation of P-Cho from SM into PtdCho involves a reaction sequence in which P-Cho is hydrolysed from SM by a sphingomyelinase, followed by incorporation of P-Cho
INTRODUCTION
Previous studies from several laboratories have shown that human fibroblasts in culture take up [3H]sphingomyelin (SM) from the medium (Beaudet & Manschrek, 1982; Maziere et al., 1982; Kudoh et al., 1983; Spence et al., 1983) . In normal fibroblasts, 50-80% of the cell-associated label is found in phosphatidylcholine (PtdCho). Studies from our laboratory using double-labelled SM ([choline-Me-3H,32P]SM) have shown that the phosphocholine (P-Cho) head group of sphingomyelin is incorporated intact into PtdCho (Spence et al., 1983) . In lysosomal sphingomyelinase-deficient cells from patients with Niemann-Pick (NP) disease, the incorporation of label from SM into PtdCho, although less than in control fibroblasts, has been observed to account for as much as 12-25 % of the cell-associated label (Spence et al., 1983; Kudoh et al., 1983) . We have suggested (Spence et al., 1983 ) that appearance of the P-Cho moiety of SM in PtdCho in NP cells may relate to the concentration of SM in the medium, since it was not observed in studies in which the exogenous SM concentration was low (Beaudet & Manschrek, 1982; Maziere et al., 1982) . The first step in the major degradative pathway of SM metabolism in mammalian tissues is the cleavage of the phosphodiester bond to form ceramide and P-Cho (Barenholz et al., 1966; Schneider & Kennedy, 1968; Rao & Spence, 1976) by sphingomyelinase (sphingomyelin phosphodiesterase; EC 3.1.4.12). The ability of sphingomyelinase-deficient NP cells to transfer the P-Cho moiety of SM to PtdCho suggested the possibility of SM degradation via additional or alternative pathways.
The present study was undertaken to determine how the PCho moiety of SM is transferred to diacylglycerol to form ceramide and PtdCho. Our previous studies showing transfer of the complete P-Cho portion (Spence et al., 1983 ) had ruled out a substantial contribution by phospholipase D or base exchange (Kanfer, 1980 ) and so we considered three other possibilities. First, a reversal of the direct transfer pathway of sphingomyelin biosynthesis may occur. Studies from several laboratories have shown a precursor-product relationship between PtdCho and SM in mammalian cells (Marggraf et al., 1972; Voelker & Kennedy, 1982; Cook et al., 1988) , but the reverse pathway has not been demonstrated. Second, there may be a reversal of the CDP-Cho pathway with CMP as an acceptor of P-Cho from SM. Such pathways with PtdCho as the P-Cho donor have been shown in rat liver and in rabbit brain neuronal nuclei (Sundler & Akesson, 1975; Baker & Chang, 1984) . The third possibility is that SM is hydrolysed by residual sphingomyelinase activity in the lysosomes or by some other unidentified sphingomyelinase, with recycling of the released P-Cho to PtdCho via the conventional CTP-dependent biosynthetic pathways (Kennedy & Weiss, 1956 (Esko & Raetz, 1980; Esko et al., 1981 (Spence et al., 1983) . Fibroblasts were grown in MEM and CHO cells were grown in Ham's F12 medium. All culture media were supplemented with 10 % fetal bovine serum and cells were maintained in a humidified atmosphere of air/CO2 (19:1) at 37°C.
Lipid substrates were prepared for the cell culture experiments as described previously (Spence et al., 1983) . Following incubation with cells, the medium was removed and in some cases analysed further to determine the identity and amounts of lipidsoluble and water-soluble radioactive materials (Spence et al., 1983; Morash et al., 1988) . The cells were harvested by scraping into 0.15 M-NaCl (Spence et al., 1983) or 2 ml of methanol/water (5:4, v/v; Morash et al., 1988) , and protein was determined by the method of Lowry et al. (1951) . Following extraction with chloroform/methanol (2:1, v/v) and partition with aqueous solvent mixtures (Folch et al., 1957) , the lipids in the lower organic phase were filtered, dried under N2, and dissolved in chloroform/methanol (2: 1, v/v). The lipid mixture was resolved by t.l.c. and radioactivity was determined by scraping the gel into vials followed by liquid scintillation spectrometry, or by using a Bioscan Imaging Scanner System 200-IBM (Bioscan Inc., Washington, DC, U.S.A.). Phospholipid mass was determined by measuring phosphorus after separation by t.l.c. (Morash et al., 1988) . Radioactivity and mass ofthe water-soluble cholinecontaining compounds in the upper phase were determined by t.l.c., or by a choline kinase assay as described previously (Morash et al., 1988) .
RESULTS
The lysosomal sphingomyelinase activity of the control fibroblasts used in these studies ranged between 30 and 160 nmol of SM cleaved/h per mg ofcell protein. By contrast, the activity in the NP cells was less than 5 % of that in controls cultured under similar conditions. Incubation of control and NP cells with exogenous SM did not appreciably alter the sphingomyelinase activity measured subsequently in vitro. As shown in Fig. 1 , NP fibroblasts were characterized by a 2-fold elevation in SM, a 35 % increase in phosphatidylethanolamine (PtdEtn), and a slight decrease in phosphatidylserine (PtdSer) and phosphatidylinositol (Ptdlns) compared with control cells. Consistent elevations in the concentration of SM and variable changes in other phospholipids have been reported in visceral tissues of patients with sphingomyelinase-deficient forms of NP disease (Fredrickson & Sloan, 1972) . When both cell types were incubated with exogenous SM (1 mM) for 48 h, there was a significant increase in SM, and this was more marked in the NP cells. In control cells, the increase was balanced in part by a decrease in PtdCho, and although a similar decrease was seen in the NP cells, it did not offset the SM accumulation. As documented previously (Spence et al., 1983) , both control and NP cells took up exogenous SM from the medium, and a portion of the incorporated lipid was converted into other lipids ( Fig. 2 ) and into water-soluble degradation products (Table 1) . In the present experiments, double-labelled [choline-Me-3H,32P]SM (Figs. 2a and 2b) and [choline-Me-3H,32P]PtdCho (Figs. 2c and 2d) were used at a higher specific radioactivity, achieved by decreasing the unlabelled carrier from 1 mm used previously (Spence et al., 1983) to a trace (-1 gM). This was done to increase the specific radioactivity of the metabolic products of the degradation of these lipids and hence provide more reliable 3H/[32P]P, ratios (Table 1) , but it also resulted in substantially less label appearing in PtdCho (Fig. 2b) in both control and NP cells. PtdCho was also taken up by both cell types (Fig. 2c ) and in these experiments uptake was less than for SM. Uptake of both lipids tended to be variable; in other experiments, we have noted similar rates of uptake for both lipids (M. Spence, unpublished work). There was a modest transfer of label from PtdCho to SM (Fig. 2d ) which amounted to < 10% of the total label uptake. (Table 1) . In both control and NP cells, the 3H/32P ratio for P-Cho was close to that of SM and PtdCho when SM was the precursor, a finding compatible with an intermediary role for PCho in label movement from SM to PtdCho. However, the specific radioactivity of P-Cho did not always exceed that of PtdCho, suggesting that if P-Cho is the immediate source of PtdCho labelling it may be derived from a higher specific radioactivity pool than is reflected by specific radioactivity measurements of the entire intracellular P-Cho pool. In contrast, Vol. 268 Table 2 . Concentrations of choline, P-Cho and GroPCho in control and NP fibroblasts following incubation with or without added SM or choline Confluent cells (60 mm dishes) were incubated for 48 h in MEM + 10 % heat-denatured fetal bovine serum with additions as noted. After incubation, the medium was removed and the cells were washed and harvested as described in the Materials and methods section. Choline, P-Cho and GroPCho were measured in the upper phase of the chloroform/methanol extract. The results suggest that movement of label from SM to PtdCho involves a sphingomyelinase reaction, which liberates free PCho, with subsequent incorporation into PtdCho. We reasoned that if this were so, increasing the intracellular P-Cho concentration should cause a decrease in labelling of PtdCho from SM. The intracellular levels of choline, P-Cho and GroPCho were not altered significantly by incubation in 1 mM-SM in either control or NP cells, but were increased by 1.5-20-fold by incubation in 4 mM-choline (Table 2 ). The increase in intracellular P-Cho was even more marked in the presence of 1 mM-SM, rising to 2-4 times the levels with added choline only ( Table 2 ). In the presence of 4 mM-choline, total lipid radioactivity in the cells (lower phase, which is SM + PtdCho) was slightly decreased in control but not in NP cells (Fig. 3) . Incorporation of [3H]choline from SM into PtdCho was decreased in both control and NP cells. The incorporation of SM label into PtdCho was lowered to 60-80% of that in the absence of added exogenous choline, which is a change in the appropriate direction, but is less than might be predicted from the expansion in the intracellular P-Cho pool. This may reflect an intracellular compartmentation of P-Cho so that the total expanded pool is not available (George et al., 1989) . Alternatively, the expansion of the P-Cho pool may occur gradually over the 48 h period ofthe experiment, so that the mean expansion may be less than that measured at 48 h.
Concentration
We have also examined the effects of various manipulations designed to alter intracellular concentrations of acceptors and other participants in the various putative transfer reactions ( aid in interpretation of the results (see footnote to Table 3 ). Diacylglycerol (dioleoyl), either as a mixed micelle with the [3H]SM or as pure micelles added separately, decreased overall label incorporation by 80%, but did not stimulate appreciably transfer of label to PtdCho, in either the presence or the absence of exogenous choline and P-Cho. The addition of linoleic acid and insulin, to increase neutral lipid formation and possibly the diacylglycerol availability, was without effect on transfer to PtdCho. Cytidine and CMP were also without effect. These results must be interpreted cautiously, since it is possible that some of these exogenous compounds were not taken up by the cells or may not have reached the site(s) of the reactions.
Although these experiments with normal and mutant human fibroblasts suggested that the most probable route for P-Cho transfer from SM to PtdCho was hydrolysis by sphingomyelinase and subsequent utilization of the released P-Cho through the usual pathways of PtdCho biosynthesis, the possibilities of a direct transfer reaction, or of reversal of the choline phosphotransferase reaction (Introduction, reactions 1 and 2)
were not excluded. The latter two reactions, however, should be relatively independent of factors that affect either the choline kinase reaction and/or the CTP: phosphocholine cytidylyltransferase reaction. Esko and co-workers (Esko & Raetz, 1980;  Esko et al., 1981) have described temperature-sensitive mutant CHO cells that are defective in cytidylyltransferase activity at the non-permissive temperature. We studied the transfer of label from SM to PtdCho in these cells (Table 4) . When cells were incubated at 33°C for 48 h and subsequently harvested and sphingomyelinase activity measured in vitro, both mutant and wild-type cells had similar sphingomyelinase activities. Growth for 48 h at 40°C had no effect on wild-type cells, but decreased activity in mutant cells by 40 
DISCUSSION
The present study was undertaken to determine the metabolic pathways by which the P-Cho moiety of exogenous SM is Vol. 268 transferred to diacylglycerol to form PtdCho in cultured human fibroblasts. Knowledge of the existence, number and types of such pathways is important for at least two reasons. First, the observation ofregulatory roles for diacylglycerol and sphingosine in protein kinase C activity Merrill et al., 1986) and the evidence that PtdCho and SM may be important precursors of those regulatory molecules (Bocckino et al., 1985; Kolesnick, 1987; Cabot et al., 1988; Silfe et al., 1989) , make knowledge of pathways which contribute to the supply of these molecules of great interest. Second, the presence of other pathways that could contribute to SM catabolism might be of practical significance for the development of treatment for the sphingomyelin lipidoses which affect man (Spence & Callahan, 1989) .
We have shown that: (1) labelled intracellular P-Cho in control and NP cells incubated with SM has a specific radioactivity intermediate between that of SM and PtdCho, which is compatible with a precursor-product relationship for P-Cho and PtdCho; (2) expansion of intracellular P-Cho by incubation with exogenous choline decreases the transfer of [3H] (Marggraf et al., 1972; Voelker & Kennedy, 1982) , cannot be excluded completely. However, the evidence is most compatible with a pathway in which most of the SM head group cycles to PtdCho through the free P-Cho intermediate. (Kudoh et al., 1983; Spence et al., 1983) and it is possible that the activity of the lysosomal sphingomyelinase at 2-3 % of normal in these cells may be adequate to provide some hydrolysis, particularly at higher substrate concentrations. Alternatively, the hydrolytic activity may be provided by the other sphingomyelinases described in mammalian tissues. Two of these are possible candidates. The neutral Mg2+-stimulated sphingomyelinase is at particularly high levels in brain, but has also been described in peripheral tissues (Spence et al., 1979) . Levels of this activity are very low in cultured fibroblasts and are not increased after incubation with exogenous SM (M. W. Spence, unpublished work). The Zn2+-stimulated enzyme found in fetal bovine serum might also play a role . Its cellular source is not known, and it may be present in a variety of tissues. Alternatively, the fetal serum enzyme may provide a source of activity to cells cultured in serum-containing medium. These possibilities require further investigation.
It is clear, from this study and others, that there is a close relationship between PtdCho and SM metabolism. Although this relationship has been known for some time insofar as the biosynthetic pathways are concerned, a close relationship, or a scavenger pathway relationship between the degradation and synthesis, has been less apparent. The present study suggests that this latter type of reaction may be important in the normal metabolism of choline-containing phospholipids.
